26 October 2017 - Independent panel members debate the evidence on the effectiveness and value of new drugs and other health care interventions at ICER public meetings.

The Institute for Clinical and Economic Review (ICER) is seeking nominations for new members to join its independent evidence review groups:

• The California Technology Assessment Forum(CTAF),
  
• The Midwest Comparative Effectiveness Public Advisory Council (Midwest CEPAC), and
  
• The New England Comparative Effectiveness Public Advisory Council (New England CEPAC).
  

These bodies are composed of leading clinicians, patient and public representatives, methodologists, and health economists. Each group convenes three times per year at public meetings to discuss ICER evidence reports, hear input from stakeholders, and vote on the strength of evidence on the effectiveness and value of new drugs, devices, and delivery system innovations.

Read ICER announcement